Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,799,175
-$8,897,207 QoQ
Shares Held
116,965
-56.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#96
of 329 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names. PCVX ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,301,919 | $269,139,417 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,302,493 | $126,967,017 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
259,468 | $48,593,167 | |
| 4 | ASND |
Ascendis Pharma A/S
|
171,447 | $45,728,343 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
1,072,830 | $41,518,521 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,081,421 | $38,271,489 | |
| 7 | FBRX |
Forte Biosciences, Inc.
|
1,439,697 | $30,593,561 | |
| 8 | ERAS |
Erasca, Inc.
|
1,308,455 | $23,970,895 |
All Filings in PCVX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,799,175 | 116,965 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,696,382 | 270,115 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,667,261 | 57,808 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,635,812 | 45,414 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $593,990 | 18,271 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $844,313 | 22,360 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $42,813,353 | 523,007 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $142,119,541 | 1,243,717 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $98,951,022 | 1,310,436 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $95,409,328 | 1,396,711 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $104,887,869 | 1,670,189 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $106,716,688 | 2,093,305 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $118,418,626 | 2,371,218 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,662,279 | 844,778 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $42,066,199 | 877,293 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $233,699 | 9,677 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||